NuPathe, Inc. Message Board
kurtmanning456
56 posts | Last Activity: May 22, 2013 1:56 PM
Member since: Dec 13, 2012
-
he said strong buy.. he has been right all along.
-
not right.
-
guess investors don't like the study. I know it's not all biotechs HALO study is a big winner that is going to Asco. The study came out and it is doing great today, so not all biotechs are down.
- Reply to
Run Up to Asco & Partnerships // Halo One to Watch at Asco May 31st.
by moneyandstocks •May 16, 2013 9:57 AM$$
- Reply to
Seeking Alpha " Study Supports HALO Drug " LINK
by michaelshepard140 •May 16, 2013 11:55 AMwow nice.
-
- Reply to
Pancreatic Cancer is A Death Sentence. Drug For This Will Be Worth a Fortune.
by mdollarsigns •May 16, 2013 10:34 AMsorry about your friend. I know many who have passed from this and a drug would certainly be a big blockbuster.
- Reply to
VP of Clinical Oncology " Study Clearly Reinforces The Treating of Pancreatic Cancer. " (post)
by michaelshepard140 •May 16, 2013 12:01 PMshould continue run up until Asco then will have alot of media coverage and news at Asco as well.
- Reply to
Interesting That SRPT CEO Would USE The Words " PARTNERING " WITH fda.
by mynameissteve258 •May 9, 2013 2:02 PMgood hint Chris
-
very true.
- Reply to
Call Says FDA Decision Made When Receive Documents, No Meeting.... read
by mdollarsigns •May 10, 2013 10:24 AMre listened to call to be sure and says decision to follow document received by FDA,,doesn;t say by phone or letter or meeting,, just says will be announced.
- Reply to
Noone Care About ACAD Earnings. It's The Future Drug They Care About.
by moneyandstocks •May 6, 2013 10:59 AMwelcome on board.
- Reply to
Earnings Don't Matter, Investors Know This is a Billion + Co.
by fromnyjohn •May 6, 2013 11:20 AMyou are correct. Acadia is The Most Undervalued Biotech on The market.